featured
2021 Top Story in Respiratory Medicine: Therapeutic Anticoagulation With Heparin in Critically Ill Patients With COVID-19
Written by
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- COVID-19 Coronavirus Pandemic. Worldometers. https://www.worldometers.info/coronavirus/. Updated December 6, 2021. Accessed December 6, 2021.
- Lopes RD, de Barros e Silva PDM, Furtado RHM, et al. Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open label, multicentre, randomized, controlled trial. Lancet. 2021;397(10291):2253-2263.
- Inspiration investigators; Sadeghipour P, Talasaz AH, Rashidi F, et al. Effect of Intermediate dose vs Standard dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment or Mortality Among Patients with COVID-19 Admitted to the Intensive Care Unit. The Inspiration Randomized Clinical Trial. JAMA. 2021;325(16):1620-1630.